Slick, buying some to basically keep on a watchlist is fine. I have not bought enough to move the dial either way just to ensure I keep abreast of them.
With regard to the US study, this seems more "at it" - Hervaxx has been slow and will only get some read out on interim Phase 2 data in 1H'20. We could all hopefully make aplenty elsewhere rather than leave dead money here.
Even the US one is 2021 - who knows where the markets will be by then.
Its called opportunity cost.
By all means a growing area, major interest by pharma, but IMU whilst with an interesting portfolio is someway off from meaningful share price moving data.
Looking forward to a 10 cent share price, page-30
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.002(5.26%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 4.0¢ | 3.7¢ | $606.5K | 15.64M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 117506 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 1949086 | 9 |
View Market Depth
| Last trade - 16.10pm 27/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
